91 related articles for article (PubMed ID: 1868451)
1. Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells.
Maxwell IH; Glode LM; Maxwell F
Cancer Res; 1991 Aug; 51(16):4299-304. PubMed ID: 1868451
[TBL] [Abstract][Full Text] [Related]
2. Cell-specific expression of the diphtheria toxin A-chain coding sequence induces cancer cell suicide.
Rui H; Chen Y
Chin Med J (Engl); 2002 Jun; 115(6):869-73. PubMed ID: 12123555
[TBL] [Abstract][Full Text] [Related]
3. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: possible strategy for inducing cancer cell suicide.
Maxwell IH; Maxwell F; Glode LM
Cancer Res; 1986 Sep; 46(9):4660-4. PubMed ID: 3460697
[TBL] [Abstract][Full Text] [Related]
4. Complex mechanisms for inhibition of immunoglobulin gene expression in a germinal center B cell line.
Bernstein RM; Mills FC; Mitchell M; Max EE
Mol Immunol; 2004 May; 41(1):63-72. PubMed ID: 15140576
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
[TBL] [Abstract][Full Text] [Related]
6. Expression of diphtheria toxin A-chain in mature B-cells: a potential approach to therapy of B-lymphoid malignancy.
Maxwell IH; Glode LM; Maxwell F
Leuk Lymphoma; 1992 Aug; 7(5-6):457-62. PubMed ID: 1493446
[TBL] [Abstract][Full Text] [Related]
7. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.
Singh H; Sen R; Baltimore D; Sharp PA
Nature; 1986 Jan 9-15; 319(6049):154-8. PubMed ID: 3079885
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
9. Enhancer sequences located 3' of the mouse immunoglobulin lambda locus specify high-level expression of an immunoglobulin lambda gene in B cells of transgenic mice.
Eccles S; Sarner N; Vidal M; Cox A; Grosveld F
New Biol; 1990 Sep; 2(9):801-11. PubMed ID: 2126202
[TBL] [Abstract][Full Text] [Related]
10. Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells.
Peng W; Chen J; Huang YH; Sawicki JA
Gene Ther; 2005 Nov; 12(21):1573-80. PubMed ID: 16034457
[TBL] [Abstract][Full Text] [Related]
11. Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells.
Abdul-Ghani R; Ohana P; Matouk I; Ayesh S; Ayesh B; Laster M; Bibi O; Giladi H; Molnar-Kimber K; Sughayer MA; de Groot N; Hochberg A
Mol Ther; 2000 Dec; 2(6):539-44. PubMed ID: 11124054
[TBL] [Abstract][Full Text] [Related]
12. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
13. Effects of enhancer mutations on the expression of human immunodeficiency virus 1-regulated luciferase and diphtheria toxin A chain genes in transfected cells.
Harrison GS; Long CJ; Castillo I
Toxicon; 1993 Jan; 31(1):85-90. PubMed ID: 8446966
[TBL] [Abstract][Full Text] [Related]
14. Development of artificial chimerical gene regulatory elements specific for cancer gene therapy.
Shin JH; Yi JK; Lee YJ; Kim AL; Park MA; Kim SH; Lee H; Kim CG
Oncol Rep; 2003; 10(6):2063-9. PubMed ID: 14534744
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
[TBL] [Abstract][Full Text] [Related]
16. In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines.
Lidor YJ; Lee WE; Nilson JH; Maxwell IH; Su LJ; Brand E; Glode LM
Am J Obstet Gynecol; 1997 Sep; 177(3):579-85. PubMed ID: 9322627
[TBL] [Abstract][Full Text] [Related]
17. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
18. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
19. Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters.
Maxwell IH; Spitzer AL; Long CJ; Maxwell F
Gene Ther; 1996 Jan; 3(1):28-36. PubMed ID: 8929909
[TBL] [Abstract][Full Text] [Related]
20. Synergism between immunoglobulin enhancers and promoters.
Garcia JV; Bich-Thuy LT; Stafford J; Queen C
Nature; 1986 Jul 24-30; 322(6077):383-5. PubMed ID: 3016550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
